Details for Patent: 8,022,082
✉ Email this page to a colleague
Which drugs does patent 8,022,082 protect, and when does it expire?
Patent 8,022,082 protects SPIRIVA and is included in one NDA.
Protection for SPIRIVA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-three patent family members in thirty countries.
Summary for Patent: 8,022,082
| Title: | Method for the administration of an anticholinergic by inhalation |
| Abstract: | An inhalation kit comprising: (a) an inhaler displaying a flow resistance of about 0.01 to 0.1 {square root over (kPa)} min/L; and (b) an inhalable powder comprising tiotropium in admixture with a physiologically acceptable excipient with an average particle size of between 10 to 500 .mu.m, and a method of administering an inhalable powder containing tiotropium in admixture with a physiologically acceptable excipient with an average particle size of between 10 .mu.m to 500 .mu.m, the method comprising actuating an inhaler a flow resistance of about 0.01 to 0.1 {square root over (kPa)} min/L containing the inhalable powder. |
| Inventor(s): | Zierenberg; Bernd (Bingen am Rhein, DE) |
| Assignee: | Boehringer Ingelheim Pharma GmbH & Co., KG (Ingelheim am Rhein, DE) |
| Application Number: | 11/427,173 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,022,082 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; Delivery; Device; |
Drugs Protected by US Patent 8,022,082
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | SPIRIVA | tiotropium bromide | POWDER;INHALATION | 021395-001 | Jan 30, 2004 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,022,082
International Family Members for US Patent 8,022,082
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 039276 | ⤷ Try a Trial | |||
| Australia | 2003226775 | ⤷ Try a Trial | |||
| Australia | 2009200716 | ⤷ Try a Trial | |||
| Brazil | 0309117 | ⤷ Try a Trial | |||
| Canada | 2481876 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
